Understanding Proteins and Skepsis Progression in Adolescent Scoliosis
Official title: UNderstanding the Causes Of Idiopathic Scoliosis Through the Longitudinal Analysis of Proteomic Markers: the UNCOIL Study
Run by University of Colorado, Denver · NCT07634627 · Data updated 2026-11-12
Researchers will test blood protein markers to see if they can predict scoliosis progression in teens with AIS or neuromuscular scoliosis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 10 Years to 17 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | December 5, 2024 |
| Main results expected | December 2029 |
| Study ends | December 2031 |
| Registry record updated | June 23, 2026 |
| Trial ID | NCT07634627 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 10-17 year-olds with idiopathic or neuromuscular scoliosis (Cobb angle 10-50°) seen at Children's Hospital Colorado.
✕Probably not a fit
Patients with Cobb angles above 50°, certain genetic conditions affecting bones or muscles, or those on medications that alter protein expression may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects clinical data and blood samples from 10-17 year-olds with idiopathic or neuromuscular scoliosis at a Children's Hospital Colorado location. Participants have two visits 6-12 months apart, during which demographic and clinical information is recorded and about 3 tablespoons of blood are drawn to measure protein biomarkers. The goal is to identify protein patterns that are associated with scoliosis progression and to compare biomarker levels between progressive and non-progressive cases, AIS versus non-AIS, and scoliosis due to neuromuscular conditions. Findings may help clarify biological factors linked to curve progression and differentiate AIS from other forms of scoliosis.
Why it matters
Potential benefit: If successful, the study could help identify biomarkers that predict scoliosis progression and guide personalized monitoring or future therapies.
How similar studies have gone: Previous studies in proteomics have shown promise in signaling musculoskeletal disease processes, but this specific approach in AIS and neuromuscular scoliosis is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 10-17 years old with idiopathic or neuromuscular scoliosis with a cobb angle of 10-50° that are currently being seen for their scoliosis at a Children's Hospital Colorado location Exclusion Criteria: * Children diagnosed with certain genetic conditions that affect the bones or muscles (Turner syndrome, down syndrome, Marfan syndrome, osteogenesis imperfecta, muscular dystrophy, Ehlers-Danlos syndrome, VATER/VACTERL syndrome, Rett syndrome, Prader Willi syndrome, or Angelman syndrome) * Patients with congenital scoliosis, early onset scoliosis (diagnosed before 9 years old), or those who have spine surgery scheduled prior to the first study visit * Patients whose spinal curve is \>50 degrees * Those taking medications that may influence protein expression (baclofen, prednisone/corticosteroids, antiepileptic medications, diazepam, tizanidine, and/or dantrolene) * Patients who are pregnant * Patients with neurocognitive disorders who are non-verbal and/or non-ambulatory * Patients who are not receiving care for scoliosis at a Children's Hospital Colorado location
Where it's running
-
Children's Hospital Colorado Anschutz
Aurora, Colorado, United States Recruiting
Study contacts
- Principal investigator: Patrick Carry, PhD — University of Colorado, Denver
- Study coordinator: Siera R Rossi, B.S.
- Email: siera.rossi@cuanschutz.edu
- Phone: 720-777-1050
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Erector spinae plane block to reduce post-operative pain after posterior spinal fusion in children
This will try giving an erector spinae plane block with ropivacaine to see if it reduces pain and the need for opioid pain medicine after posterior spinal fusion in children with adolescent idiopathic or neuromuscular scoliosis.
-
Comparing pooled human plasma and crystalloid for children undergoing spinal fusion for scoliosis
This study is testing whether using pooled human plasma instead of a standard fluid can help reduce blood loss during spinal surgery for scoliosis in teenagers.
-
Turkish version of the Scoliosis Misconception Scale for adolescents with AIS
This study tests a Turkish version of the Scoliosis Misconception Scale in 200 adolescents with AIS to see if the questions reliably measure misconceptions about scoliosis.
-
Hypnosis to reduce pain and nausea after scoliosis surgery in teens
Teens aged 12–18 undergoing scoliosis surgery will try preoperative hypnosis to see if it lowers pain, nausea, and opioid use after surgery.
-
Supervised vs. Home Schroth Exercises for Adolescent Idiopathic Scoliosis
This study tests whether supervised Schroth exercises work better than a home-based program for teens with AIS.
-
Sleep quality in adolescents with scoliosis
This study tests whether adolescents with idiopathic scoliosis have different sleep quality than healthy peers aged 10–18.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.